AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
ROSUVASTATIN in Rwanda
3 products registered with RDA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LDNIL 20 Film Coated Tablet | RWANDA-FDA24/HM/0550/0065 | MSN LABORATORIES LIMITED | active | 7 May 2031 |
| STATINOR 10 Tablets | Rwanda FDA-HMP-MA-2251 | HETERO LABS LIMITED | active | 3 Feb 2030 |
| STATINOR 20 Tablets | Rwanda FDA-HMP-MA-2252 | HETERO LABS LIMITED | active | 3 Feb 2030 |
ROSUVASTATIN — RDA Registration Details
RDA (Rwanda) has 3 registered products containing ROSUVASTATIN, of which 3 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track ROSUVASTATIN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.